HOME >> MEDICINE >> NEWS
Vitamin supplement use may reduce effects of Alzheimer's disease

Antioxidant vitamin supplements, particularly vitamins E and C, may protect the aging brain against damage associated with the pathological changes of Alzheimer's disease, according to a study conducted by the Johns Hopkins Bloomberg School of Public Health and other institutions. The researchers believe antioxidant vitamin supplements may be an ideal prevention strategy for our aging population as they are relatively nontoxic and are thought to have wide-ranging health benefits. The study, "Reduced Risk of Alzheimer's Disease in Users of Antioxidant Vitamin Supplements" is published in the January 2004, issue of the journal Archives of Neurology.

Peter P. Zandi, PhD, lead author of the study and an assistant professor in the School's Department of Mental Health, said, "These results are extremely exciting. Our study suggests that the regular use of vitamin E in nutritional supplement doses, especially in combination with vitamin C, may reduce the risk of developing Alzheimer's disease."

The researchers examined data from the Cache County Study, which is a large, population-based investigation of the prevalence and incidence of Alzheimer's disease and other dementias. Residents who were 65 or older were assessed from 1996-1997 and again from 1998-2000. Study participants were asked at their first contact about vitamin usage. The researchers then compared the subsequent risk of developing Alzheimer's disease over the study interval among supplement users versus nonusers to come to their conclusions.

Approximately 17 percent of the study participants reported taking vitamin E or C supplements. These individuals were significantly more likely to be female, younger, better educated and reported better general health when compared to non-supplement users. In addition to those who took vitamin supplements, another 20 percent of study participants used multivitamins, but without a high dosage of vitamin E or C.

The researchers found a tren
'"/>

Contact: Kenna Brigham
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
19-Jan-2004


Page: 1 2

Related medicine news :

1. Vitamin E may not prevent cancer or cardiovascular events, but may increase risk for heart failure
2. Vitamin C reduces level of C-reactive protein, finds UC Berkeley-led study
3. Vitamins good for some older women/bad for others
4. Vitamin B-12 levels linked to bone loss in aging women
5. Vitamins help treat depression
6. Vitamin D deficiency emerges as new epidemic
7. Vitamins C and E improve cardiovascular health in children with high cholesterol, study says
8. Vitamins C and E may enhance effectiveness of insulin for diabetes
9. Vitamins valuable for baby boomers eye disease
10. Vitamin E fails to join heart-health regimen
11. Vitamins C and E support breathing following an operation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vitamin supplement use may reduce effects Alzheimer disease

(Date:5/22/2013)... and Los Angeles, CA (PRWEB) May 22, 2013 ... the board, The J. M. Smucker Company, and ... Achievement Awards yesterday at the GS1 General Assembly and ... California. Mr. Smucker and Mr. Wegman were recognized for ... GS1 Standards - the most broadly used supply chain ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Children and teens exposed ... likely to develop cancer, according to a large, long-term ... a group of 10,000 young people who each had ... be expected to occur within 10 years, according to ... doctors should carefully weight the risks to patients when ...
(Date:5/22/2013)... available in German . ... Foundation) is establishing 11 new Research Training Groups to ... was made by the relevant Grants Committee in Bonn. ... to the new programmes for an initial period of ... 11 new Research Training Groups, the Grants Committee approved ...
(Date:5/22/2013)... run, encouraging a baby to finish the last ounce in ... Though the calories soon burn off, a bad habit remains. ... Forste found that clinical obesity at 24 months of age ... overweight at age two, it puts you on a trajectory ... and adolescence and as an adult," said Forste. "That,s a ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
(Date:5/22/2013)... -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it ... enrollment required for its Phase I trial to evaluate the ... Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common ... no Severe Adverse Effect (SAE) reported. The Phase ... NIH under number NCT01828762 (click here to view) ...
(Date:5/22/2013)... May 22, 2013 PRNewswire – iBio, ... of a vaccine candidate for the newly emerged ... laboratory using the iBioLaunch™ platform. This validation milestone ... initial antigen sequence information to purification of recombinant ... ) The iBioLaunch platform eliminates the ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
Cached News: